News Search Results
Jan 12, 2026, 09:10 ET 10x Genomics to Advance Research in Diagnostic Applications of Tumor Single Cell and Spatial Profiling
should not be relied upon as representing 10x Genomics, Inc.'s views as of any date subsequent to the date of this press release. 10x Genomics, Inc. disclaims any obligation to update any forward-looking statements provided to reflect any change in 10x Genomics' expectations or any change in events, conditions
More news about: 10x Genomics, Inc.
Jan 12, 2026, 09:00 ET Cancer Research Institute Launches Transformative AI-Driven Immuno-Oncology Initiative Powered by 10x Genomics Technology
should not be relied upon as representing 10x Genomics, Inc.'s views as of any date subsequent to the date of this press release. 10x Genomics, Inc. disclaims any obligation to update any forward-looking statements provided to reflect any change in 10x Genomics' expectations or any change in events, conditions
More news about: 10x Genomics, Inc.
Jan 11, 2026, 12:00 ET 10x Genomics Announces Preliminary Select Fourth Quarter and Full Year 2025 Results
recently-filed 10-K, 10-Q and elsewhere in the documents 10x Genomics, Inc. files with the Securities and Exchange Commission from time to time. 10x Genomics' products are for research use only (RUO) and are not for use in diagnostic procedures. "10x Genomics", "Chromium" and "Xenium" are trademarks of 10x. 10x
More news about: 10x Genomics, Inc.
Dec 29, 2025, 16:05 ET 10x Genomics to Present at the 44th Annual J.P. Morgan Healthcare Conference
https://investors.10xgenomics.com/. The webcast will be archived and available for replay for at least 30 days after the event.About 10x Genomics10x Genomics is a life science technology company building products to accelerate the mastery of biology and advance human health. Our integrated
More news about: 10x Genomics, Inc.
Nov 20, 2025, 10:01 ET Genomics Market worth $85.09 billion by 2030 with 12.6% CAGR | MarketsandMarkets™
Nanopore Technologies Plc. (UK), Takara Bio Inc. (Japan), BGI Group (China), Eppendorf SE (Germany), Merck KGaA (Germany), BD (US), Abbott (US), 10X Genomics, Inc. (US), New England Biolabs (US), Promega Corporation (US), Creative Biogene (US), Novogene Co., Ltd. (China), Helix, Inc. (US), Phalanx Biotech
More news about: MarketsandMarkets
Nov 18, 2025, 09:00 ET New ASTRA Consortium Unites Asia-Pacific Scientists to Build Pan-Cancer Spatial Atlas Powered by 10x Genomics' Xenium
outline plans to scale the atlas across cancer types, institutions, and regional hubs. About 10x Genomics10x Genomics is a life science technology company building products to accelerate the mastery of biology and advance human health. Our integrated
More news about: 10x Genomics, Inc.
Nov 11, 2025, 16:05 ET 10x Genomics to Participate in the Wolfe Research Healthcare Conference 2025
archived and available for replay for at least 30 days after the event. About 10x Genomics 10x Genomics is a life science technology company building products to accelerate the mastery of biology and advance human health.
More news about: 10x Genomics, Inc.
Nov 06, 2025, 16:05 ET 10x Genomics Reports Third Quarter 2025 Financial Results
should not be relied upon as representing 10x Genomics, Inc.'s views as of any date subsequent to the date of this press release. 10x Genomics, Inc. disclaims any obligation to update any forward-looking statements provided to reflect any change in 10x Genomics' expectations or any change in events, conditions
More news about: 10x Genomics, Inc.
Oct 29, 2025, 09:00 ET 10x Genomics Launches the Next Generation of Chromium Flex to Empower Scientists to Massively Scale Single Cell Research
10xgenomics.com or contact your 10x Genomics representative. About 10x Genomics10x Genomics is a life science technology company building products to accelerate the mastery of biology
More news about: 10x Genomics, Inc.
Oct 24, 2025, 06:22 ET Weekly Recap: 12 Tech Press Releases You Need to See
10x Genomics and Anthropic Partner to Make Single Cell and Spatial Analysis More Accessible Through Claude for Life Sciences Using
More news about: PR Newswire
Oct 20, 2025, 12:30 ET 10x Genomics and Anthropic Partner to Make Single Cell and Spatial Analysis More Accessible Through Claude for Life Sciences
should not be relied upon as representing 10x Genomics, Inc.'s views as of any date subsequent to the date of this press release. 10x Genomics, Inc. disclaims any obligation to update any forward-looking statements provided to reflect any change in 10x Genomics' expectations or any change in events, conditions
More news about: 10x Genomics, Inc.
Oct 16, 2025, 14:02 ET Alamar Biosciences élargit son équipe de direction pour assurer la prochaine phase de croissance
25 ans d'expérience en matière de leadership opérationnel et financier dans divers secteurs et a joué un rôle déterminant dans l'entrée en bourse de 10x Genomics en 2019, dont il a été le directeur financier pendant plus de cinq ans. Justin a occupé pendant plus de trois ans le poste de vice-président des
More news about: Alamar Biosciences, Inc.
Oct 16, 2025, 14:01 ET Alamar Biosciences erweitert die Führungsspitze für die nächste Wachstumsphase
Erfahrung in leitenden Positionen im operativen und finanziellen Bereich in verschiedenen Branchen und war maßgeblich an der Börsennotierung von 10x Genomics im Jahr 2019 beteiligt, wo er über fünf Jahre lang als Finanzleiter tätig war. Justin war über drei Jahre lang als Vizepräsident für weltweite Finanzen
More news about: Alamar Biosciences, Inc.
Oct 16, 2025, 14:00 ET Alamar Biosciences amplía su liderazgo ejecutivo para impulsar la siguiente fase de crecimiento
financiero. Justin aporta más de 25 años de experiencia en liderazgo operativo y financiero en diversos sectores y fue clave para la salida a bolsa de 10x Genomics en 2019, ejerciendo como su director financiero durante más de cinco años. Justin fue vicepresidente de Finanzas y Operaciones Mundiales de Tesla
More news about: Alamar Biosciences, Inc.
Oct 16, 2025, 13:59 ET Alamar Biosciences расширяет руководящий штат для обеспечения следующего этапа роста
директора. Джастин обладает более чем 25-летним опытом операционного и финансового руководства в различных секторах и сыграл важную роль в преобразовании 10X Genomics в акционерную компанию в 2019 году, проработав в качестве ее финансового директора более пяти лет. Джастин более 3 лет занимал должность вице-президента
More news about: Alamar Biosciences, Inc.
Oct 16, 2025, 13:58 ET Spoločnosť Alamar Biosciences rozširuje svoje výkonné vedenie, aby zvládla ďalšiu fázu rastu
riaditeľa. Justin má viac ako 25-ročné skúsenosti s prevádzkovým a finančným vedením v rôznych sektoroch a zohral kľúčovú úlohu pri vstupe spoločnosti 10x Genomics na burzu v roku 2019, keď viac ako päť rokov pôsobil ako jej finančný riaditeľ. Justin zastával viac ako 3 roky pozíciu viceprezidenta spoločnosti
More news about: Alamar Biosciences, Inc.
Oct 16, 2025, 13:57 ET Alamar Biosciences poszerza skład zespołu zarządczego, aby przejść na kolejny etap rozwoju
doświadczenia w zakresie zarządzania operacyjnego i finansowego w różnych sektorach i odegrał kluczową rolę w procesie wprowadzenia spółki 10x Genomics na giełdę w 2019 r., pełniąc funkcję dyrektora finansowego przez ponad pięć lat. Wcześniej przez ponad trzy lata był wiceprezesem ds. finansów
More news about: Alamar Biosciences, Inc.
Oct 16, 2025, 13:55 ET Alamar Biosciences rozšiřuje výkonné vedení pro další fázi růstu
než 25 let zkušeností s provozním a finančním vedením v různých odvětvích, působil mimo jiné více než pět let jako finanční ředitel společnosti 10x Genomics a v roce 2019 sehrál klíčovou roli při jejím vstupu na burzu. Přes 3 roky také působil na postu viceprezidenta pro globální finance a provoz ve
More news about: Alamar Biosciences, Inc.
Oct 15, 2025, 09:12 ET Alamar Biosciences Expands Executive Leadership to Power Next Phase of Growth
Financial Officer. Justin brings over 25 years of operational and financial leadership experience across various sectors and was instrumental in taking 10x Genomics public in 2019, serving as its CFO for over five years. Justin served for over 3 years as Tesla's VP of Worldwide Finance and Operations, supporting
More news about: Alamar Biosciences, Inc.
Oct 15, 2025, 09:12 ET Alamar Biosciences Expands Executive Leadership to Power Next Phase of Growth
Financial Officer. Justin brings over 25 years of operational and financial leadership experience across various sectors and was instrumental in taking 10x Genomics public in 2019, serving as its CFO for over five years. Justin served for over 3 years as Tesla's VP of Worldwide Finance and Operations, supporting
More news about: Alamar Biosciences, Inc.
Oct 09, 2025, 16:05 ET 10x Genomics to Report Third Quarter 2025 Financial Results on November 6, 2025
archived and available for replay for at least 45 days after the event. About 10x Genomics 10x Genomics is a life science technology company building products to accelerate the mastery of biology and advance human health.
More news about: 10x Genomics, Inc.
Sep 17, 2025, 11:48 ET Precision Cell Systems Completes Two Acquisitions to Consolidate Best-in-Class Technologies Serving 700+ Customers for Cell Analysis
industry veterans with proven track records. CEO Anup Parikh previously held leadership roles at Mission Bio and 10X Genomics. He is joined by Chief Commercial Officer Terry Salyer, who drove revenue growth at Unchained Labs and ProteinSimple,
More news about: Precision Cell Systems
Sep 09, 2025, 09:00 ET CLISEQ, 10X Genomics and Weizmann Institute to Investigate Single Cell Applications in Hematology Clinical Diagnostics
should not be relied upon as representing 10x Genomics, Inc.'s views as of any date subsequent to the date of this press release. 10x Genomics, Inc. disclaims any obligation to update any forward-looking statements provided to reflect any change in 10x Genomics' expectations or any change in events, conditions
More news about: 10x Genomics, Inc.
Sep 08, 2025, 10:28 ET August in Review: 12 Top Technology Press Releases
10x Genomics to Acquire Scale Biosciences The acquisition will support an ambitious multi-year product roadmap for single cell innovation – one that
More news about: PR Newswire
Sep 05, 2025, 06:12 ET August in Review: 13 Top Health Press Releases
10x Genomics to Acquire Scale Biosciences The acquisition provides 10x with key inventions and technologies that will advance innovation across
More news about: PR Newswire